Literature DB >> 11675843

Seizures associated with fluoroquinolones.

J M Kushner1, H J Peckman, C R Snyder.   

Abstract

OBJECTIVE: To report two cases of seizures following administration of levofoxacin and ciprofloxacin. CASE
SUMMARY: A 75-year-old white woman admitted to the hospital was prescribed levofloxacin for ischemic toes. After receiving three doses of oral levofloxacin, the patient experienced a seizure. One month later, the patient was rechallenged with ciprofloxacin and again experienced a seizure. The patient was hypomagnesemic and had elevated serum creatinine at the time of both seizures, and was hyponatremic during the second seizure. A 74-year-old white woman admitted to the hospital was prescribed levofloxacin for bacterial pneumonia. After five doses, the patient experienced a seizure. The woman had no electrolyte imbalances at the time of the seizure and no history of a seizure disorder. DISCUSSION: Quinolone antibiotics vary in their ability to induce seizures, with trovafloxacin having the greatest potential and levofloxacin possibly having the least potential. Neither patient had a history of a previous seizure disorder. Electrolyte imbalances are common with previous reports of fluoroquinolone-induced seizures.
CONCLUSIONS: Although levofloxacin monotherapy has not been implicated in inducing seizures, it appears to be the causative agent in the second case. In the first case, the quinolones may have been a necessary, but not sufficient, cause in a patient with electrolyte abnormalities. Risk factors for fluoroquinolone-induced seizures may Include seizure history, electrolyte imbalances,dose unadjusted for renal insufficiency, and concomitant treatment with agents that lower the seizure threshold.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11675843     DOI: 10.1345/aph.10359

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  22 in total

1.  Status epilepticus attributed to moxifloxacin in an adolescent patient with spina bifida occulta.

Authors:  Liang Qiao; Xin Cui; Yongjie Li
Journal:  Eur J Clin Pharmacol       Date:  2010-08-31       Impact factor: 2.953

2.  Levofloxacin-induced seizures in a patient without predisposing risk factors: the impact of pharmacogenetics.

Authors:  Cristina Gervasoni; Dario Cattaneo; Felicia Stefania Falvella; Paola Vitiello; Stefania Cheli; Laura Milazzo; Emilio Clementi; Agostino Riva
Journal:  Eur J Clin Pharmacol       Date:  2013-04-25       Impact factor: 2.953

3.  Sustained ocular delivery of ciprofloxacin using nanospheres and conventional contact lens materials.

Authors:  Rahul Garhwal; Sally F Shady; Edward J Ellis; Jeanne Y Ellis; Charles D Leahy; Stephen P McCarthy; Kathryn S Crawford; Peter Gaines
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-13       Impact factor: 4.799

Review 4.  Safety considerations of fluoroquinolones in the elderly: an update.

Authors:  Ralf Stahlmann; Hartmut Lode
Journal:  Drugs Aging       Date:  2010-03-01       Impact factor: 3.923

5.  Association of antibiotics with status epilepticus.

Authors:  Usha K Misra; Jayantee Kalita; Satish Chandra; Pradeep P Nair
Journal:  Neurol Sci       Date:  2012-03-07       Impact factor: 3.307

Review 6.  Safety profile of the fluoroquinolones: focus on levofloxacin.

Authors:  Hans H Liu
Journal:  Drug Saf       Date:  2010-05-01       Impact factor: 5.606

Review 7.  Nervous system effects of antituberculosis therapy.

Authors:  Joseph S Kass; Wayne X Shandera
Journal:  CNS Drugs       Date:  2010-08       Impact factor: 5.749

Review 8.  Fluoroquinolones in the elderly: safety considerations.

Authors:  Ralf Stahlmann; Hartmut Lode
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

9.  A seizure attributed to ofloxacine in a woman undergoing detoxification for alcohol dependence.

Authors:  Pierre Lahmek; Laurent Michel; Nadine Meunier; Henri-Jean Aubin
Journal:  Case Rep Med       Date:  2010-01-24

Review 10.  Seizures associated with levofloxacin: case presentation and literature review.

Authors:  Alfredo Bellon; Gonzalo Perez-Garcia; John H Coverdale; Ranjit C Chacko
Journal:  Eur J Clin Pharmacol       Date:  2009-08-26       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.